RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Solitary Fibrous Tumour: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Sinonasal Solitary Fibrous Tumor Mimicking a Small Round Cell Neoplasm on Frozen Section.
Fan Jiamei et al., Ear, nose, & throat journal (11 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42859921/
- 2.
A Case of Malignant Solitary Fibrous Tumor of the Hepatic Falciform Ligament
Kenichiro Shimazaki et al., Cureus (4 October 2026)
https://doi.org/10.7759/cureus.117420
- 3.
Risk Stratification and Clinical Outcome in Extrameningeal Solitary Fibrous Tumours: A Single Institution Experience.
A. Gomes et al. (1 October 2026)
https://doi.org/10.13140/rg.2.2.31149.24804
- 4.
Black-and-white sign of intracranial solitary fibrous tumor.
He Yanmei et al., Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (1 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42349069/
- 5.
PSMA-avid Pleural Solitary Fibrous Tumor Incidentally Detected on [ 18 F] Piflufolastat PSMA PET/CT.
Guglielmo Priscilla et al., Clinical nuclear medicine (1 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42545177/
Clinical Trials : Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
NCT06789172 · Recruiting · Phase 1 · Epkin
Ages 18 and over
https://clinicaltrials.gov/study/NCT06789172
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Solitary Fibrous Tumour
Solitary fibrous tumour is a rare soft tissue tumour that can arise almost anywhere in the body, including the lining of the lungs, the abdomen, the brain coverings and the limbs. Most grow slowly and are not cancerous, but some can spread or return. Surgery is the main treatment, with radiotherapy or medicines considered for advanced disease. Long-term follow-up is important.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Solitary Fibrous Tumour?
Solitary fibrous tumour is a rare soft tissue tumour that can arise almost anywhere in the body, including the lining of the lungs, the abdomen, the brain coverings and the limbs. Most grow slowly and are not cancerous, but some can spread or return. Surgery is the main treatment, with radiotherapy or medicines considered for advanced disease. Long-term follow-up is important.
How many clinical trials are available for Solitary Fibrous Tumour?
RareWays currently indexes 8 clinical trials for Solitary Fibrous Tumour, of which 2 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Solitary Fibrous Tumour come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Solitary Fibrous Tumour.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.